Login / Signup

Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial.

Philippe DenisChristoph HirneißGeorges M DurrKasu Prasad ReddyAnita KamarthyErnesto CalvoZubair HussainIqbal K Ahmed
Published in: The British journal of ophthalmology (2020)
NCT03193736.
Keyphrases
  • endothelial cells
  • study protocol
  • clinical trial
  • phase iii
  • induced pluripotent stem cells
  • pluripotent stem cells
  • ultrasound guided
  • phase ii
  • type diabetes
  • metabolic syndrome